TrialEuropean urology oncology2024

A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer.

Ritesh R Kotecha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.